Press Releases - 2023-01-10

Date	Title	Company
10-Jan-2023	Sernova and Evotec on Track to Initiate Clinical Testing of the First iPSC-Derived Islets in Cell Pouch as a Potential Functional Cure for Type 1 Diabetes	Sernova Corp.
10-Jan-2023	BRAIN Biotech AG: BRAIN Group's Akribion Genomics business will prioritize the development of therapeutic applications within its CRISPR technology platform	BRAIN Biotech AG
10-Jan-2023	BRAIN Biotech AG: prioritizing development of therapeutic applications of the Akribion Genomics technology platform (genome-editing)	BRAIN Biotech AG
10-Jan-2023	Shift to consumer-first mindset is highest priority for digital pharma products going into 2023	Graphite Digital
10-Jan-2023	Phastar enhances Data Visualization and Analytics solution through acquisition of S-Cubed ApS, adds capability in Denmark	Phastar
10-Jan-2023	Medios AG: Successful completion of the acquisition of bbw – Significant expansion of compounding volume	Medios AG
10-Jan-2023	No More Needles: TRUMPF and RSP Systems Want to Make Blood Glucose Monitoring Easier for People with Diabetes	TRUMPF Photonic Components
10-Jan-2023	iTeos Provides Business Updates and Clinical Development Plans for 2023	iTeos Therapeutics
10-Jan-2023	atai Life Sciences Company GABA Therapeutics Announces Positive Final Results from Phase 1 Single and Multiple Ascending Dose Trial of GRX-917	atai Life Sciences
10-Jan-2023	SK PHARMTECO APPOINTS DAVID LOWNDES AS CHIEF OPERATING OFFICER	SK PHARMTECO
10-Jan-2023	Sirio Pharma Successfully Completes the Acquisition of Best Formulations	Sirio Pharma
10-Jan-2023	Lynred launches HEROIC, €18M European Defence Fund project to produce strategic electronics for next-generation infrared sensors	Andrew Lloyd Associates
10-Jan-2023	Inflexion provides Partnership Capital minority funding to Proteros	Inflexion
10-Jan-2023	ProtonDx and Katalyst Announce Strategic Partnership to Distribute Dragonfly™ In Vitro Diagnostic	ProtonDx
10-Jan-2023	finnCap Cavendish advises on the sale of MBI Healthcare Technologies to DNV	finnCap Cavendish
10-Jan-2023	Viralgen receives cGMP certification to produce rAAV commercial grade product at new facility in San Sebastian, Spain	Viralgen
10-Jan-2023	Kelso Pharma appoints UK Managing Director	Kelso Pharma
10-Jan-2023	BC Platforms Selected as Partner to Deliver key Singapore Population Health Study	BC Platforms
10-Jan-2023	Positive Initial Data Analysis in POLB 001 LPS Challenge Trial	Poolbeg Pharma Plc
10-Jan-2023	ExeVir Bio secures EUR 25 million venture debt financing from the European Investment Bank	ExeVir Bio